Ultragenyx Pharmaceutical (RARE) Shares Issued (2013 - 2024)

Ultragenyx Pharmaceutical (RARE) has 11 years of Shares Issued data on file, last reported at $381.0 million in Q2 2024.

• Quarterly Shares Issued changed N/A year-over-year to $381.0 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $390.1 million (changed N/A YoY) and the FY2025 annual result came in at $6.0 million, down 45.45% from the prior year.
• Shares Issued grew to $381.0 million in Q2 2024 per RARE's latest filing, from $2.0 million in the prior quarter.
• Across five years, Shares Issued topped out at $381.0 million in Q2 2024 and bottomed at $380000.0 in Q1 2020.
• The 4-year median for Shares Issued is $9.8 million (2021), against an average of $45.3 million.
• The widest annual swing landed in 2020, when Shares Issued tumbled 99.88%; it then soared 3258.16% in 2021.
• Tracing RARE's Shares Issued over 4 years: stood at $79.8 million in 2020, then slumped by 91.32% to $6.9 million in 2021, then slumped by 71.1% to $2.0 million in 2022, then surged by 18940.48% to $381.0 million in 2024.
• Per Business Quant, the three latest RARE Shares Issued figures stand at $381.0 million (Q2 2024), $2.0 million (Q4 2022), and $1.1 million (Q3 2022).

Peer Comparison